There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - Senate

Short Title(s) as Introduced

Henrietta Lacks Enhancing Cancer Research Act of 2019

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to direct the Comptroller General of the United States to complete a study on barriers to participation in federally funded cancer clinical trials by populations that have been traditionally underrepresented in such trials.

Actions Overview (1)

Date Actions Overview
03/28/2019Introduced in Senate

All Actions (1)

Date All Actions
03/28/2019Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Action By: Senate

Cosponsors (7)

* = Original cosponsor
CosponsorDate Cosponsored
Sen. Cardin, Benjamin L. [D-MD]* 03/28/2019
Sen. Collins, Susan M. [R-ME] 09/17/2020
Sen. Whitehouse, Sheldon [D-RI] 09/17/2020
Sen. Jones, Doug [D-AL] 09/17/2020
Sen. Gillibrand, Kirsten E. [D-NY] 09/23/2020
Sen. Tester, Jon [D-MT] 09/23/2020
Sen. Smith, Tina [D-MN] 10/22/2020

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Related Documents
Senate Health, Education, Labor, and Pensions03/28/2019 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.

Subjects (8)

Latest Summary (1)

There is one summary for S.946. View summaries

Shown Here:
Introduced in Senate (03/28/2019)

Henrietta Lacks Enhancing Cancer Research Act of 2019

This bill requires the Government Accountability Office to complete a study reviewing how federal agencies address barriers to participation in federally-funded cancer clinical trials by individuals from underrepresented populations and provide recommendations for addressing such barriers.